Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AJJ Medtech HoldingsSGX:584 Market Cap is S$6.93 Mil as of Jul. 18, 2026. The stock has 4 warning signs investors should review. Among 866 Medical Devices & Instruments companies, AJJ Medtech Holdings ranks worse than 90.53% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AJJ Medtech Holdings's share price for the quarter that ended in Mar. 2026 was S$0.006. AJJ Medtech Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 1,711.54 Mil. Therefore, AJJ Medtech Holdings's market cap for the quarter that ended in Mar. 2026 was S$10.27 Mil.
AJJ Medtech Holdings's quarterly market cap
increased
from Sep. 2025 (S$9.02 Mil) to Dec. 2025 (S$17.12 Mil) but then
declined
from Dec. 2025 (S$17.12 Mil) to Mar. 2026 (S$10.27 Mil).
AJJ Medtech Holdings's annual market cap
declined
from Dec. 2023 (S$6.54 Mil) to Dec. 2024 (S$4.51 Mil) but then
increased
from Dec. 2024 (S$4.51 Mil) to Dec. 2025 (S$17.12 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AJJ Medtech Holdings's Enterprise Value for Today is S$8.95 Mil.
AJJ Medtech Holdings (SGX:584) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
AJJ Medtech Holdings Market Cap Related Terms
AJJ Medtech Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for AJJ Medtech Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, AJJ Medtech Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AJJ Medtech Holdings Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AJJ Medtech Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where AJJ Medtech Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
AJJ Medtech Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AJJ Medtech Holdings (SGX:584) has a Market Cap of S$6.93 Mil as of Jul. 18, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AJJ Medtech Holdings and its competitors. According to the industry distribution chart, AJJ Medtech Holdings ranks #784 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 90.5%.
Is AJJ Medtech Holdings' Market Cap too high?
AJJ Medtech Holdings' current Market Cap is S$6.93 Mil. Based on the distribution chart, AJJ Medtech Holdings ranks #784 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does AJJ Medtech Holdings' Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, AJJ Medtech Holdings ranks #784 out of 866 companies for Market Cap. This places AJJ Medtech Holdings in the lower half of its industry. The industry median Market Cap is 115.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 115.63, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AJJ Medtech Holdings and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 115.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AJJ Medtech Holdings's current Market Cap is S$6.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AJJ Medtech Holdings stock overvalued right now?
Based on GuruFocus' analysis, AJJ Medtech Holdings (SGX:584) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.01, compared to a current price of S$0.00 — trading 60% below its estimated fair value. The current Market Cap is S$6.93 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For AJJ Medtech Holdings (SGX:584), the current Market Cap is S$6.93 Mil as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AJJ Medtech Holdings Ltd is a healthcare technology company building an integrated platform across medical devices, digital systems, and intelligent care infrastructure in Singapore, Southeast Asia, and selected international markets. It integrates artificial intelligence, robotics, and healthcare systems to support healthcare delivery across the patient care continuum. Its portfolio includes diagnostic systems, medical and dental devices, consumables, digital and robotics-enabled healthcare solutions, and turn-key supply-chain solutions. Its segments are corporate and investment holding, healthcare products and services, and healthcare digital products, which generate maximum revenue. It operates mainly in Singapore, and its revenue is derived from the sale of medical healthcare products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:584 has been successfully added to your 
